0.8188
price down icon0.87%   -0.0072
after-market アフターアワーズ: .82 0.0012 +0.15%
loading

Cue Biopharma Inc (CUE) 最新ニュース

pulisher
Aug 18, 2025

Cue Biopharma Inc. stock daily chart insightsSwing Trade & Safe Investment Capital Preservation Plans - Newser

Aug 18, 2025
pulisher
Aug 18, 2025

Regression analysis insights on Cue Biopharma Inc. performanceLong Setup & Real-Time Buy Signal Notifications - Newser

Aug 18, 2025
pulisher
Aug 17, 2025

Published on: 2025-08-17 18:02:43 - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Intraday pattern recognizer results for Cue Biopharma Inc.Oil Prices & Verified Technical Signals - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Evaluating Cue Biopharma Inc. with trendline analysis2025 AllTime Highs & Daily Chart Pattern Signals - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Is Cue Biopharma Inc. trading at a discount2025 Support & Resistance & Target Return Focused Stock Picks - thegnnews.com

Aug 17, 2025
pulisher
Aug 17, 2025

Why Cue Biopharma Inc. stock attracts strong analyst attention2025 Macro Impact & Low Drawdown Momentum Ideas - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

How to read the order book for Cue Biopharma Inc.Risk Management & Real-Time Buy Signal Alerts - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

What makes Cue Biopharma Inc. stock price move sharplyIPO Watch & Free Fast Entry Momentum Trade Alerts - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

How to recover losses in Cue Biopharma Inc. stockShare Buyback & Daily Oversold Bounce Ideas - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Will Cue Biopharma Inc. stock go up soon2025 Historical Comparison & Weekly Top Gainers Trade List - Newser

Aug 17, 2025
pulisher
Aug 16, 2025

News impact scoring models applied to Cue Biopharma Inc.July 2025 Intraday Action & Daily Stock Trend Reports - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Should you avoid Cue Biopharma Inc. stock right nowFed Meeting & Low Risk High Reward Trade Ideas - thegnnews.com

Aug 16, 2025
pulisher
Aug 16, 2025

Using AI based signals to follow Cue Biopharma Inc.Take Profit & Real-Time Chart Breakout Alerts - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Why Cue Biopharma Inc. stock is on top investor watchlistsJuly 2025 Decliners & Fast Gaining Stock Strategy Reports - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

How sentiment analysis helps forecast Cue Biopharma Inc.Market Activity Report & Daily Profit Maximizing Trade Tips - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Will Cue Biopharma Inc. stock benefit from interest rate changesJuly 2025 Outlook & Stepwise Entry/Exit Trade Alerts - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Published on: 2025-08-16 02:15:50 - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Is Cue Biopharma Inc. forming a bottoming baseEarnings Summary Report & AI Driven Stock Movement Reports - Newser

Aug 16, 2025
pulisher
Aug 15, 2025

Order flow analysis tools used on Cue Biopharma Inc.2025 Market Outlook & Verified Short-Term Trading Plans - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Intrinsic Value of Cue Biopharma Inc. Stock: Is It Undervalued or OvervaluedWeekly Profit Report & Low Drawdown Investment Ideas - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

How Cue Biopharma Inc. stock performs during market volatilityDip Buying & Stepwise Trade Execution Plans - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Cue Biopharma Inc. Building a Base Near SupportStop Loss & Entry Point Strategy Guides - sundaytimes.kr

Aug 15, 2025
pulisher
Aug 15, 2025

What technical models suggest about Cue Biopharma Inc.’s comeback - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Cue Biopharma Reports Q2 2025 Earnings: Collaboration Revenue Exceeds Estimate, Net Loss Narrows - AInvest

Aug 15, 2025
pulisher
Aug 14, 2025

Cue Biopharma's Q2 2025 Earnings Beat and Revenue Growth: A Glimpse of Sustainable Turnaround Potential? - AInvest

Aug 14, 2025
pulisher
Aug 13, 2025

Cue Biopharma Announces Initiation of Investigator Sponsored Tri - GuruFocus

Aug 13, 2025
pulisher
Aug 13, 2025

Cue Biopharma announces initiation of investigator sponsored trial of CUE-102 - TipRanks

Aug 13, 2025
pulisher
Aug 13, 2025

Cue Biopharma Announces Initiation of Investigator Sponsored Trial of CUE-102 in Recurrent Glioblastoma Multiforme - The Manila Times

Aug 13, 2025
pulisher
Aug 13, 2025

Dana-Farber Launches Trial of New Immunotherapy Drug for Aggressive Brain Cancer - Stock Titan

Aug 13, 2025
pulisher
Aug 13, 2025

Cue Biopharma Inc. Facing Inflection Point in Trend Analysis2025 Buyback Activity & Weekly Top Performers Watchlists - sundaytimes.kr

Aug 13, 2025
pulisher
Aug 13, 2025

Cue Biopharma Inc. stock daily chart insights [July 2025 Recap]Consistent Profit Trade Alerts - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Cue Biopharma 2025 Q2 Earnings Narrowed Losses with Modest Revenue Growth - AInvest

Aug 13, 2025
pulisher
Aug 13, 2025

Can machine learning forecast Cue Biopharma Inc. recoveryFree Risk Controlled Picks With Real Returns - Newser

Aug 13, 2025
pulisher
Aug 12, 2025

Advanced analytics toolkit walkthrough for Cue Biopharma Inc.Trade Exit Summary & AI Based Buy and Sell Signals - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

Short interest data insights for Cue Biopharma Inc.Free Consistent Gain Investment Strategies - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

Cue Biopharma earnings beat by $0.05, revenue topped estimates - Investing.com Canada

Aug 12, 2025
pulisher
Aug 12, 2025

Cue Biopharma, Inc. (CUE) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance

Aug 12, 2025
$35.92
price down icon 1.18%
$84.92
price down icon 2.30%
$26.29
price down icon 1.50%
$127.27
price down icon 0.41%
$112.55
price down icon 0.85%
biotechnology ONC
$319.32
price down icon 0.63%
大文字化:     |  ボリューム (24 時間):